Bibliographic Details
Title: |
Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas. |
Authors: |
Oravecz, Orsolya, Balogh, Andrea, Romero, Roberto, Xu, Yi, Juhasz, Kata, Gelencser, Zsolt, Xu, Zhonghui, Bhatti, Gaurav, Pique-Regi, Roger, Peterfia, Balint, Hupuczi, Petronella, Kovalszky, Ilona, Murthi, Padma, Tarca, Adi L., Papp, Zoltan, Matko, Janos, Than, Nandor Gabor |
Source: |
International Journal of Molecular Sciences; May2022, Vol. 23 Issue 10, p5798-5798, 20p |
Subject Terms: |
TROPHOBLAST, PROTEOGLYCANS, FETAL growth retardation, PREGNANCY complications, PLACENTA, PREGNANCY outcomes, ECLAMPSIA, ABRUPTIO placentae |
Abstract: |
Proteoglycan macromolecules play key roles in several physiological processes (e.g., adhesion, proliferation, migration, invasion, angiogenesis, and apoptosis), all of which are important for placentation and healthy pregnancy. However, their precise roles in human reproduction have not been clarified. To fill this gap, herein, we provide an overview of the proteoglycans' expression and role in the placenta, in trophoblast development, and in pregnancy complications (pre-eclampsia, fetal growth restriction), highlighting one of the most important members of this family, syndecan-1 (SDC1). Microarray data analysis showed that of 34 placentally expressed proteoglycans, SDC1 production is markedly the highest in the placenta and that SDC1 is the most upregulated gene during trophoblast differentiation into the syncytiotrophoblast. Furthermore, placental transcriptomic data identified dysregulated proteoglycan genes in pre-eclampsia and in fetal growth restriction, including SDC1, which is supported by the lower concentration of syndecan-1 in maternal blood in these syndromes. Overall, our clinical and in vitro studies, data analyses, and literature search pointed out that proteoglycans, as important components of the placenta, may regulate various stages of placental development and participate in the maintenance of a healthy pregnancy. Moreover, syndecan-1 may serve as a useful marker of syncytialization and a prognostic marker of adverse pregnancy outcomes. Further studies are warranted to explore the role of proteoglycans in healthy and complicated pregnancies, which may help in diagnostic or therapeutic developments. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |
Full text is not displayed to guests. |
Login for full access.
|